WZ4003

CAS No. 1214265-58-3

WZ4003 ( WZ4003; WZ-4003; WZ 4003 )

Catalog No. M10799 CAS No. 1214265-58-3

WZ4003 is a highly specific NUAK kinase inhibitor with IC50 of 20 nM and 100 nM for NUAK1 and NUAK2, respectively.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 39 In Stock
10MG 63 In Stock
25MG 107 In Stock
50MG 160 In Stock
100MG 241 In Stock
200MG 357 In Stock
500MG 590 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    WZ4003
  • Note
    Research use only, not for human use.
  • Brief Description
    WZ4003 is a highly specific NUAK kinase inhibitor with IC50 of 20 nM and 100 nM for NUAK1 and NUAK2, respectively.
  • Description
    WZ4003 is a highly specific NUAK kinase inhibitor with IC50 of 20 nM and 100 nM for NUAK1 and NUAK2, respectively, without significant inhibition on 139 other kinases.
  • Synonyms
    WZ4003; WZ-4003; WZ 4003
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    AMPK
  • Recptor
    NUAK1; NUAK2
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1214265-58-3
  • Formula Weight
    496.99
  • Molecular Formula
    C25H29ClN6O3
  • Purity
    >98%(HPLC)
  • Solubility
    DMSO:7 mg/mL (14.08 mM); Ethanol:<1 mg/mL (<1 mM); Water:<1 mg/mL (<1 mM)
  • SMILES
    CCC(NC1=CC=CC(OC2=NC(NC3=CC=C(N4CCN(C)CC4)C=C3OC)=NC=C2Cl)=C1)=O
  • Chemical Name
    N-[3-[[5-chloro-2-[[2-methoxy-4-(4-methyl-1-piperazinyl)phenyl]amino]-4-pyrimidinyl]oxy]phenyl]-propanamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Banerjee S, et al. Biochem J. 2014, 457(1), 215-225.
molnova catalog
related products
  • AICAR phosphate

    AICAR phosphate (Acadesine, AICA Riboside, NSC 105823) is a selective AMPK activator in both hepatocytes and adipocytes.

  • GSK621

    GSK621 (GSK-621) is a potent, specific AMPK agonist (activator), induces cytotoxicity in AML (IC50=13-30 uM).

  • BC1618

    BC1618 is an orally active Fbxo48 inhibitory compound, stimulates Ampk-dependent signaling.